Trial intelligence / Profile preview

Local gentamicin for prevention of cardiac pacemaker implant infection

RBR-33dd28cPhase 2Completed

Sponsor
UniSALESIANO
Start
Aug 2024
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of gentamicin in Cardiac Device Infection (CIEDI), sponsored by UniSALESIANO. Started Aug 2024; status: completed.

02

Drugs

gentamicin
03

Conditions

Cardiac Device Infection (CIEDI)

Beyond the preview

Go deeper on RBR-33dd28c.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-33dd28c.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call